SCHEMBL4466273

SCHEMBL4466273

COc1ccc(C2CC(=O)c3c(O)cc(O)c(O)c3O2)cc1O

nearest known ligand 0.69

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CYP19A1 P11511 4/20 0.69
▸ MAPT P10636 3/20 0.69
▸ TP53 P04637 2/20 0.69
▸ CYP3A4 P08684 2/20 0.69
▸ XDH P47989 2/20 0.69
▸ CYP1A1 P04798 2/20 0.69
▸ CYP1A2 P05177 2/20 0.69
▸ CYP1B1 Q16678 2/20 0.69
▸ ATM Q13315 2/20 0.69
▸ KDM1A O60341 2/20 0.69
▸ HPGD P15428 1/20 0.69
▸ SMN1; SMN2 Q16637 1/20 0.69
▸ PKM P14618 1/20 0.69
▸ NPC1 O15118 1/20 0.69
▸ CA12 O43570 1/20 0.69
▸ ALDH1A1 P00352 1/20 0.69
▸ CYP2D6 P10635 1/20 0.69
▸ CYP2C9 P11712 1/20 0.69
▸ TSHR P16473 1/20 0.69
▸ CA4 P22748 1/20 0.69

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4175838 1.00 CYP19A1 (0.69) CYP19A1MAPTTP53CYP3A4XDH
SCHEMBL2124058 0.87 CYP19A1 (0.68) CYP19A1MAPTTP53CYP3A4XDH
SCHEMBL12878874 0.84 CYP19A1 (0.65) CYP19A1MAPTTP53CYP3A4XDH
Hesperetin SCHEMBL765368 0.82 CYP19A1 (1.00) CYP19A1MAPTTP53CYP3A4XDH
Hesperetin SCHEMBL29534477 0.82 CYP19A1 (1.00) CYP19A1MAPTTP53CYP3A4XDH
Hesperetin SCHEMBL29359052 0.82 CYP19A1 (1.00) CYP19A1MAPTTP53CYP3A4XDH
Hesperetin SCHEMBL31689737 0.82 CYP19A1 (1.00) CYP19A1MAPTTP53CYP3A4XDH
Hesperetin SCHEMBL39833 0.82 CYP19A1 (1.00) CYP19A1MAPTTP53CYP3A4XDH
Hesperetin SCHEMBL20929082 0.82 CYP19A1 (1.00) CYP19A1MAPTTP53CYP3A4XDH
Hesperetin SCHEMBL29484563 0.82 CYP19A1 (1.00) CYP19A1MAPTTP53CYP3A4XDH

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7582675-B2 Flavonoid compound and process for producing the same POKKA CORPORATION (JP) 2009-09-01 — — US disclosed
US-7582675-B2 Flavonoid compound and process for producing the same POKKA CORPORATION (JP) 2009-09-01 — — US disclosed
US-7582675-B2 Flavonoid compound and process for producing the same POKKA CORPORATION (JP) 2009-09-01 — — US disclosed
US-20060270009-A1 Flavonoid compound and process for producing the same NATIONAL UNIVERSITY CORPORATION NAGOYA UNIVERSITY (JP) 2006-11-30 — — US disclosed
US-7138429-B2 Flavonoid compound and process for producing the same JAPAN SCI. TECH. CORP. (JP) 2006-11-21 — — US disclosed
EP-1369489-B1 FLAVONOID COMPOUND AND PROCESS FOR PRODUCING THE SAME JAPAN SCIENCE & TECH CORP (JP) 2006-08-23 — — EP disclosed
US-20040152762-A1 Flavonoid compound and process for producing the same NATIONAL UNIVERSITY CORPORATION NAGOYA UNIVERSITY (JP) 2004-08-05 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040152762-A1 Flavonoid compound and process for producing the same ERG28, TFPI, HES1 CYP19A1 279/4885MAPT 3583/4885TP53 3131/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback